Skip to main content
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc. — Investor Relations & Filings

Ticker · VKTX ISIN · US92686J1060 LEI · 529900IVC72YPFA25M37 US Professional, scientific and technical activities
Open in API
Filings indexed 608 across all filing types
Latest filing 2024-05-23 Transaction in Own Shar…
Country US United States of America
Listing US VKTX

About Viking Therapeutics, Inc.

https://vikingtherapeutics.com/

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's pipeline is centered on small molecule drug candidates designed to address these conditions.

Recent filings

Filing Released Lang Actions
S-8 POS
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to multiple Form S-8 Registration Statements filed with the SEC by Viking Therapeutics, Inc. Form S-8 is used for registering securities to be offered under employee benefit plans, such as equity incentive plans. The document discusses amendments to prior registration statements related to the 2014 and 2024 Equity Incentive Plans, including details about shares issuable under these plans. It is a regulatory filing related to securities registration and amendments, not a financial report, earnings release, or other report types. The document is lengthy (15,000 characters) and contains detailed regulatory information about securities registration amendments. Therefore, the appropriate classification is Transaction in Own Shares (POS), which covers share repurchase/issuance and related filings such as Form S-8 amendments.
2024-05-23 English
S-8 POS
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to multiple Form S-8 Registration Statements filed with the SEC by Viking Therapeutics, Inc. It references registration of shares under equity incentive plans and updates to prior registration statements. The document is a regulatory filing related to securities registration and amendments to previously filed Form S-8 statements. It does not contain financial statements, earnings data, or management discussion, nor is it a report or announcement of voting results or capital changes. The Form S-8 is a registration statement for securities issued under employee benefit plans, and this document is an amendment to those filings. Therefore, the document fits best under the category of Transaction in Own Shares (POS), which covers share repurchase/issuance and related filings, including registration statements for equity plans.
2024-05-22 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans and employee stock purchase plans. It includes detailed information about the securities being registered, references to other SEC filings (10-K, 10-Q, 8-K), and legal provisions related to indemnification of directors and officers. It is not a financial report, earnings release, or management discussion, but a regulatory filing specifically for securities registration under the Securities Act of 1933. Therefore, it fits the category of Regulatory Filings (RNS) as it does not match any other more specific report type and is a general SEC filing for registration purposes.
2024-05-22 English
FORM 4 SUBMISSION
Director's Dealing
2024-05-04 English
Regulatory Filings 2024
Regulatory Filings
2024-05-03 English
FORM 4 SUBMISSION
Director's Dealing
2024-05-03 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.